Target intelligence / Profile preview

Glycoinositolphosphosphingolipid (GIPSL)

Target
GIPSL
Molecular classification
Glycosphingolipid, Sphingolipid, Other
01

Overview

Glycoinositolphosphosphingolipids, frequently referred to as basidiolipids in the context of higher mushrooms, are specialized sphingolipids that are essential for the structural integrity of fungal cell membranes. These molecules are characterized by a ceramide core attached to an inositol phosphate group, which is further substituted with various carbohydrate chains that vary between species. Biologically, basidiolipids play a vital role in maintaining the fungal plasma membrane, participating in polarized growth, and mediating intracellular signaling pathways crucial for environmental adaptation and virulence. Because their chemical structure is distinct from mammalian sphingolipids, they are investigated as unique targets for the development of selective antifungal agents, such as inositol phosphorylceramide (IPC) synthase inhibitors like Aureobasidin A. Additionally, basidiolipids possess significant immunomodulatory properties and are being studied as potential vaccine adjuvants and anticancer agents due to their ability to activate innate immunity and stimulate cytokine production. They also act as antigens that can be recognized by human heterophile antibodies, making them relevant for both diagnostic biomarker research and the study of fungal-host interactions.

Other names
BasidiolipidsFungal glycosphingolipidAcidic glycosphingolipidFungal sphingolipidMushroom lipid
02

Mechanism of action

Inhibition of inositol phosphorylceramide (IPC) synthase or direct binding to the lipid moiety leading to membrane disruption and fungal cell death.

03

Biological functions

Signal transductionImmune responseCell deathOther
04

Disease associations

InfectionCancerInflammationOther
05

Safety considerations

Potential for hypersensitivityImmunogenicityCross-reactivity with host glycosphingolipids
06

Interacting drugs

Aureobasidin A

4 more in the full profile.

07

Biomarkers

Anti-glycoinositolphosphosphingolipid antibody

Beyond the preview

Go deeper on Glycoinositolphosphosphingolipid (GIPSL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycoinositolphosphosphingolipid (GIPSL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call